ArticleThe Journal of antimicrobial chemotherapy2023

Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study.

Danny Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.